Literature DB >> 1753879

Neutralizing monoclonal antibodies to Pasteurella haemolytica leukotoxin affinity-purify the toxin from crude culture supernatants.

M J Gentry1, S Srikumaran.   

Abstract

The leukotoxin of Pasteurella haemolytica is a major virulence factor of the organism. It is an unstable protein which has proven very difficult to purify using traditional techniques. Hybridomas secreting monoclonal antibodies (mAbs) to P. haemolytica leukotoxin were derived from spleen cells of a mouse immunized with crude culture supernatant. Five hybridomas secreting mAbs specific for the leukotoxin were stabilized. Each of the mAbs reacted with a protein of approximately 100 kDa in toxic culture supernatants, and two of them completely neutralized the toxin in vitro. Affinity chromatography of crude culture supernatant on a column prepared with one of the neutralizing mAbs resulted in the isolation of biologically active toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1753879     DOI: 10.1016/0882-4010(91)90086-p

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  27 in total

1.  Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.

Authors:  P K Stevens; C J Czuprynski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  A multivalent Mannheimia-Bibersteinia vaccine protects bighorn sheep against Mannheimia haemolytica challenge.

Authors:  Renuka Subramaniam; Sudarvili Shanthalingam; Jegarubee Bavananthasivam; Abirami Kugadas; Kathleen A Potter; William J Foreyt; Douglas C Hodgins; Patricia E Shewen; George M Barrington; Donald P Knowles; Subramaniam Srikumaran
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Mannheimia (Pasteurella) haemolytica leukotoxin binding domain lies within amino acids 1 to 291 of bovine CD18.

Authors:  R S Gopinath; T C Ambagala; M S Deshpande; R O Donis; S Srikumaran
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Comparison of passively transferred antibodies in bighorn and domestic lambs reveals one factor in differential susceptibility of these species to Mannheimia haemolytica-induced pneumonia.

Authors:  Caroline N Herndon; Sudarvili Shanthalingam; Donald P Knowles; Douglas R Call; Subramaniam Srikumaran
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

5.  Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.

Authors:  N D Fedorova; S K Highlander
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Precise gene editing paves the way for derivation of Mannheimia haemolytica leukotoxin-resistant cattle.

Authors:  Sudarvili Shanthalingam; Ahmed Tibary; Jonathan E Beever; Poothapillai Kasinathan; Wendy C Brown; Subramaniam Srikumaran
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

7.  Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects.

Authors:  S Jeyaseelan; M S Kannan; R E Briggs; P Thumbikat; S K Maheswaran
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7.

Authors:  M E Bauer; R A Welch
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Intact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin.

Authors:  Sudarvili Shanthalingam; Subramaniam Srikumaran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

10.  Acylation Enhances, but Is Not Required for, the Cytotoxic Activity of Mannheimia haemolytica Leukotoxin in Bighorn Sheep.

Authors:  Sai A Batra; Sudarvili Shanthalingam; Gerhard R Munske; Bindu Raghavan; Abirami Kugadas; Jegarubee Bavanthasivam; Sarah K Highlander; Subramaniam Srikumaran
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.